Australia markets closed

Chimeric Therapeutics Limited (CHM.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.03000.0000 (0.00%)
At close: 03:57PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
Operating expenses
Research development
5,174
13,475
5,174
3,778
Selling general and administrative
10,201
11,924
9,138
6,168
Total operating expenses
17,190
29,487
17,190
15,691
Operating income or loss
-17,190
-29,487
-17,190
-15,691
Interest expense
640.127
773.845
640.127
5.877
Total other income/expenses net
2,082
4,826
2,082
-263.79
Income before tax
-15,735
-25,408
-15,735
-15,114
Income tax expense
163.72
92.82
163.72
0
Income from continuing operations
-15,898
-25,500
-15,898
-15,114
Net income
-15,898
-25,500
-15,898
-15,114
Net income available to common shareholders
-15,898
-25,500
-15,898
-15,114
Basic EPS
-0.06
-0.06
-0.04
-0.08
Diluted EPS
-0.06
-0.06
-0.04
-0.08
Basic average shares
433,245
433,245
359,932
188,717
Diluted average shares
433,245
433,245
359,932
188,717